04:51 PM EDT, 07/23/2024 (MT Newswires) -- Fady Ibraham Malik, Executive Vice President, Research & Development, on July 23, 2024, sold 7,300 shares in Cytokinetics ( CYTK ) for $416,246. Following the Form 4 filing with the SEC, Malik has control over a total of 129,004 shares of the company, with 129,004 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224020876/xslF345X03/form4.xml

Price: 59.81, Change: +2.43, Percent Change: +4.23